NMI-377, an NO-donating diclofenac derivative with decreased GI side effects Aug. 26, 1999 No Comments
Advances in the immunotherapy of cocaine abuse at Scripps Research Institute Aug. 26, 1999 No Comments
Cardioselective potassium channel blocker advances to phase II trials at HMR Aug. 25, 1999 No Comments
Tanabe Seiyaku pursues integrin receptor antagonists, with interesting results Aug. 25, 1999 No Comments
Tanabe Seiyaku-Pharmacia & Upjohn collaboration provides new leads in inflammation research Aug. 25, 1999 No Comments
ACS presentation for Parke-Davis's selective NR1a/2B receptor antagonist PD-188669 Aug. 25, 1999 No Comments
RSS